Z
Zosano Pharma Corp
F:0ZPN
Zosano Pharma Corp
F:0ZPN
Price:
0.525
EUR
Market Closed
Market Cap:
€18.9m
Relative Value
There is not enough data to reliably calculate the relative value of 0ZPN.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
0ZPN
Relative Value
Base Case
Not Available
Multiples Across Competitors
0ZPN Competitors Multiples
Zosano Pharma Corp Competitors
Zosano Pharma Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
Z
|
Zosano Pharma Corp
F:0ZPN
|
18.9m EUR | 33.8 | -0.4 | -0.3 | -0.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
195.6B USD | 4.4 | 30 | 17.2 | 23.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
175.3B USD | 17.4 | 61.4 | 46.6 | 57.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
140B USD | 5.6 | 43.1 | 21.9 | 26.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
117.2B USD | 3.3 | 25.4 | 13.9 | 20.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.6B USD | 5.3 | 36.8 | 21.6 | 28.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.2B EUR | 1.9 | 21.4 | 11.8 | 16.7 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.9B USD | 8.1 | 45.6 | 25.1 | 27.5 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
48.7B USD | 11.3 | 45.9 | 32.6 | 36.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
47.1B USD | 2.1 | 26.8 | 10.5 | 17.7 | |
| US |
|
Resmed Inc
NYSE:RMD
|
36.8B USD | 6.8 | 24.8 | 17.5 | 19.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
